Castro, Karen
Naik, Chetan A.
Spak, Cedric W.
Askar, Medhat
Pittmon, Leah
Williams, Jenifer
Vandervest, Katherine
Endicott-Yazdani, Tiana
Grazia, Todd J.
Gottlieb, Robert L.
Mathai, Susan K.
Article History
Accepted: 18 January 2024
First Online: 24 February 2024
Compliance with Ethical Standards
:
: Dr. Gottlieb has received consulting fees from AbbVie, Astra Zeneca, Eli Lilly, Gilead Sciences, GSK Pharmaceuticals, and Roche, all related to COVID-19. He has served on a steering committee for a Roivant Sciences COVID-19 clinical trial and acted as the coordinating investigator for a Johnson and Johnson COVID-19 clinical trial. Both roles are outside the scope of the current work. Additionally, Dr. Gottlieb has received a gift-in-kind for Baylor Scott and White Research Institute to support the unrelated academic-sponsored clinical trial (NCT03383419). Dr. Askar is a member of the scientific advisory board for One Lambda (a subsidiary of Thermo Fisher). Dr. Mathai reports participation as an investigator on a COVID-19 clinical trial funded by Foresee Pharmaceuticals (NCT04750278); she is an investigator on other trials outside the scope of this work funded by Boehringer Ingelheim, the National Institutes of Health, Cumberland Pharmaceuticals, ATyr Pharma, and the US Department of Defense. She has received fees for medical advisory activities for Natera and Verona Pharmaceuticals and for Data Safety and Monitoring Board participation from Mt. Sinai School of Medicine outside the scope of this work. Dr. Grazia reports receiving grants from Gates Grubstakes Grant (GGF014-18–13). He also reports associations with several other initiatives outside the scope of this work, including Renovion RVN-001—ARINA-1 in Bilateral Lung Transplant, Alberta Transplant Applied Genomics Center in collaboration with Natera, Sanofi, Pulmocide Ltd, and with Zambon Pharmaceuticals: BOSTON-1, BOSTON-2, and BOSTON-3. Additionally, Dr. Grazia holds a U.S. Patent (CU TTO File No. CU2425H-PPA1, U.S. Patent Application No. 13/394,625 issued) and a European Patent (covering Britain, France, and Germany; no. 2475379 issued). All other authors, namely, CAN, CWS, LP, JW, KC, KV, and TEY, have declared no relevant conflicts of interest concerning this manuscript.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). The retrospective data was gathered via two existing retrospective protocols for lung transplant and SARS-CoV-2 approved by the Baylor Scott and White Research Institute Institutional Review Board.